Early offering transcatheter aortic valve replacement to patients with moderate aortic stenosis: quantifying costs and benefits - a Markov model-based simulation study.

Dieu NguyenTom MarwickMarj MoodieLan Gao

Published in: BMJ open (2023)

While ongoing randomised controlled trials will define the benefit of TAVI to MAS patients, these results suggest that this intervention is likely to be cost-effective.

Keyphrases

aortic stenosis
transcatheter aortic valve replacement
ejection fraction
aortic valve
aortic valve replacement
transcatheter aortic valve implantation
left ventricular
newly diagnosed
coronary artery disease
high intensity
patient reported outcomes